Induction of xenobiotic enzymes by the MAP kinase pathway and the antioxidant or electrophile response element (ARE/EpRE)
- PMID:11768769
- DOI: 10.1081/dmr-120000652
Induction of xenobiotic enzymes by the MAP kinase pathway and the antioxidant or electrophile response element (ARE/EpRE)
Abstract
Cellular responses to xenobiotic-induced stress can signal proliferation, differentiation, homeostasis, apoptosis, or necrosis. To better understand the underlying molecular mechanisms after exposure to xenobiotics or drugs, we studied the signal transduction pathways, the mitogen-activated protein kinase (MAPK), and the basic leucine zipper transcription factor Nrf2, activated by different agents in the induction of Phase II drug metabolizing enzymes (DMEs). The MAPKs, characterized as proline-directed serine/threonine kinases, are essential components of signaling pathways that convert various extracellular signals into intracellular responses through serial phosphorylation cascades. Once activated, MAPKs can phosphorylate many transcription factors, such as c-Jun, ATF-2, and ultimately lead to changes in gene expression. Two classes of Phase II gene inducers, which are also cancer chemopreventive agents, were studied: (1) the phenolic antioxidants, namely butylated hydroxyanisole (BHA) and its active de-methylated metabolite t-butylhydroquinone (tBHQ), and phenolic flavonoids such as green tea polyphenols (GTP) and (-)-epigallocatechin-3-gallate (EGCG); and (2) the naturally occurring isothiocyanates, namely phenethyl isothiocyanate (PEITC), and sulforaphane. BHA and tBHQ are both well-known phenolic antioxidants used as food preservatives, and strongly activate c-Jun N-terminal kinase 1 (JNK1), extracellular signal-regulated protein kinase 2 (ERK2), or p38, in a time- and dose-dependent fashion. Free radical scavengers N-acetyl-L-cysteine (NAC), or glutathione (GSH), inhibited ERK2 activation and, to a much lesser extent, JNK1 activation by BHA/tBHQ, implicating the role of oxidative stress. Under conditions where MAPKs were activated, BHA or GTP also activated ARE/EpRE (antioxidant/electrophile response element), with the induction of Phase II genes such as NQO. Transfection studies with various cDNAs encoding wild-type or dominant-negative mutants of MAPKs and/or transcription factor Nrf2, substantially modulated ARE-mediated luciferase reporter activity in the presence or absence of phenolic compounds. Other phytochemicals including PEITC, and sulforaphane, also differentially regulated the activities of MAPKs, Nrf2, and ARE-mediated luciferase reporter gene activity and Phase II enzyme induction. A model is proposed where these xenobiotics (BHA, tBHQ, GTP, EGCG, PEITC, sulforaphane) activate the MAPK pathway via an electrophilic-mediated stress response, leading to the transcription activation of Nrf2/Maf heterodimers on ARE/EpRE enhancers, with the subsequent induction of cellular defense/detoxifying genes including Phase II DMEs, which may protect the cells against toxic environmental insults and thereby enhance cell survival. The studies of these signaling pathways may yield insights into the fate of cells upon exposure to xenobiotics.
Similar articles
- Differential activation of MAPK and ICE/Ced-3 protease in chemical-induced apoptosis. The role of oxidative stress in the regulation of mitogen-activated protein kinases (MAPKs) leading to gene expression and survival or activation of caspases leading to apoptosis.Kong AN, Yu R, Lei W, Mandlekar S, Tan TH, Ucker DS.Kong AN, et al.Restor Neurol Neurosci. 1998 Jun;12(2-3):63-70.Restor Neurol Neurosci. 1998.PMID:12671299
- Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes.Rushmore TH, Kong AN.Rushmore TH, et al.Curr Drug Metab. 2002 Oct;3(5):481-90. doi: 10.2174/1389200023337171.Curr Drug Metab. 2002.PMID:12369894Review.
- Induction of phase I, II and III drug metabolism/transport by xenobiotics.Xu C, Li CY, Kong AN.Xu C, et al.Arch Pharm Res. 2005 Mar;28(3):249-68. doi: 10.1007/BF02977789.Arch Pharm Res. 2005.PMID:15832810Review.
- Butylated hydroxyanisole and its metabolite tert-butylhydroquinone differentially regulate mitogen-activated protein kinases. The role of oxidative stress in the activation of mitogen-activated protein kinases by phenolic antioxidants.Yu R, Tan TH, Kong AN.Yu R, et al.J Biol Chem. 1997 Nov 14;272(46):28962-70. doi: 10.1074/jbc.272.46.28962.J Biol Chem. 1997.PMID:9360968
- Signal transduction events elicited by cancer prevention compounds.Kong AN, Yu R, Hebbar V, Chen C, Owuor E, Hu R, Ee R, Mandlekar S.Kong AN, et al.Mutat Res. 2001 Sep 1;480-481:231-41. doi: 10.1016/s0027-5107(01)00182-8.Mutat Res. 2001.PMID:11506817Review.
Cited by
- Dietary chemoprevention strategies for induction of phase II xenobiotic-metabolizing enzymes in lung carcinogenesis: A review.Tan XL, Spivack SD.Tan XL, et al.Lung Cancer. 2009 Aug;65(2):129-37. doi: 10.1016/j.lungcan.2009.01.002. Epub 2009 Jan 31.Lung Cancer. 2009.PMID:19185948Free PMC article.Review.
- Identification of the Crucial Gene in Overflow Arteriovenous Fistula by Bioinformatics Analysis.Zhao Z, Fu Q, Hu L, Liu Y.Zhao Z, et al.Front Physiol. 2021 Aug 4;12:621830. doi: 10.3389/fphys.2021.621830. eCollection 2021.Front Physiol. 2021.PMID:34421628Free PMC article.
- Preventive and therapeutic effects of MG132 by activating Nrf2-ARE signaling pathway on oxidative stress-induced cardiovascular and renal injury.Cui W, Bai Y, Luo P, Miao L, Cai L.Cui W, et al.Oxid Med Cell Longev. 2013;2013:306073. doi: 10.1155/2013/306073. Epub 2013 Mar 7.Oxid Med Cell Longev. 2013.PMID:23533688Free PMC article.Review.
- Starvation, detoxification, and multidrug resistance in cancer therapy.Lee C, Raffaghello L, Longo VD.Lee C, et al.Drug Resist Updat. 2012 Feb-Apr;15(1-2):114-22. doi: 10.1016/j.drup.2012.01.004. Epub 2012 Mar 4.Drug Resist Updat. 2012.PMID:22391012Free PMC article.Review.
- Transcription factors in the cellular signaling network as prime targets of chemopreventive phytochemicals.Surh YJ.Surh YJ.Cancer Res Treat. 2004 Oct;36(5):275-86. doi: 10.4143/crt.2004.36.5.275. Epub 2004 Oct 30.Cancer Res Treat. 2004.PMID:20368816Free PMC article.
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous